Display options
Share it on

Biol Open. 2012 Aug 15;1(8):731-8. doi: 10.1242/bio.2012968. Epub 2012 Jun 12.

The endocytic adapter E-Syt2 recruits the p21 GTPase activated kinase PAK1 to mediate actin dynamics and FGF signalling.

Biology open

Steve Jean, Michel G Tremblay, Chelsea Herdman, François Guillou, Tom Moss

Affiliations

  1. Present address: Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093-0380, USA.

PMID: 23213466 PMCID: PMC3507230 DOI: 10.1242/bio.2012968

Abstract

Fibroblast growth factor (FGF) signalling plays an essential role in early vertebrate development. However, the response to FGF requires endocytosis of the activated FGF receptor (FGFR) that is in part dependent on remodelling of the actin cytoskeleton. Recently we showed that the extended synaptotagmin family plasma membrane protein, E-Syt2, is an essential endocytic adapter for FGFR1. Here we show E-Syt2 is also an interaction partner for the p21-GTPase Activated Kinase PAK1. The phospholipid binding C2C domain of E-Syt2 specifically binds a site adjacent to the CRIB/GBD of PAK1. PAK1 and E-Syt2 selectively complex with FGFR1 and functionally cooperate in the FGF signalling. E-Syt2 binding suppresses actin polymerization and inhibits the activation of PAK1 by the GTPases Cdc42 and Rac. Interestingly, the E-Syt2 binding site on PAK1 extensively overlaps a site recently suggested to bind phospholipids. Our data suggest that PAK1 interacts with phospholipid membrane domains via E-Syt2, where it may cooperate in the E-Syt2-dependent endocytosis of activated FGFR1 by modulating cortical actin stability.

Keywords: Cortical actin; E-Syt2; Endocytosis; Extended synaptotagmin; FGF receptor; FGF signalling; PAK1; p21-GTPase activated kinase

References

  1. Chem Biol. 2008 Apr;15(4):322-31 - PubMed
  2. Annu Rev Biochem. 2003;72:743-81 - PubMed
  3. Nature. 1987 Mar 12-18;326(6109):197-200 - PubMed
  4. Development. 2007 Jul;134(14):2651-61 - PubMed
  5. J Cell Biol. 2005 Jan 31;168(3):429-39 - PubMed
  6. Nature. 2005 Jul 7;436(7047):78-86 - PubMed
  7. Cell. 1987 Dec 4;51(5):869-77 - PubMed
  8. Dev Cell. 2005 Aug;9(2):167-8 - PubMed
  9. Development. 2005 Feb;132(4):805-16 - PubMed
  10. Nat Cell Biol. 1999 Sep;1(5):253-9 - PubMed
  11. Endocr Rev. 2005 Feb;26(1):63-77 - PubMed
  12. J Cell Biol. 2002 Aug 19;158(4):695-708 - PubMed
  13. Clin Exp Metastasis. 2010 Oct;27(7):481-91 - PubMed
  14. Nat Rev Mol Cell Biol. 2011 Jul 22;12(8):517-33 - PubMed
  15. Mol Cell. 2010 Nov 12;40(3):493-500 - PubMed
  16. EMBO J. 1998 Aug 3;17(15):4328-39 - PubMed
  17. PLoS Biol. 2011 Mar;9(3):e1000604 - PubMed
  18. J Cell Biol. 1998 Nov 30;143(5):1361-73 - PubMed
  19. EMBO J. 1994 Oct 3;13(19):4469-81 - PubMed
  20. Mol Biol Cell. 2005 Feb;16(2):964-75 - PubMed
  21. Nat Rev Genet. 2006 May;7(5):360-72 - PubMed
  22. Nat Cell Biol. 2004 Jan;6(1):38-44 - PubMed
  23. Science. 1999 Mar 26;283(5410):2083-5 - PubMed
  24. Dev Cell. 2010 Sep 14;19(3):426-39 - PubMed
  25. Arteriosclerosis. 1990 Mar-Apr;10(2):215-22 - PubMed
  26. Dev Dyn. 2009 Jul;238(7):1709-26 - PubMed
  27. Mol Cell. 2002 Jan;9(1):73-83 - PubMed
  28. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3823-8 - PubMed
  29. Nat Cell Biol. 2011 Aug 14;13(9):1124-31 - PubMed
  30. Nat Cell Biol. 2002 Sep;4(9):681-90 - PubMed
  31. Dev Biol. 2003 Nov 15;263(2):264-81 - PubMed
  32. Curr Opin Cell Biol. 2010 Feb;22(1):36-43 - PubMed
  33. Mol Biol Cell. 2007 Mar;18(3):1030-43 - PubMed

Publication Types